Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer-Reference-Cited by-同舟云学术

Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer

Published:2014-03-03 Issue:11 Volume:120 Page:1620-1629
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Roach Mack¹²

Affiliation:

1. Department of Radiation Oncology; University of California at San Francisco; San Francisco California

2. Department of Urology; University of California at San Francisco; San Francisco California

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference65 articles.

1. High-risk prostate cancer: from definition to contemporary management;Bastian;Eur Urol,2012

2. Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines;Mohler;J Natl Compr Canc Netw,2012

3. Survival following primary androgen deprivation therapy among men with localized prostate cancer;Lu-Yao;JAMA,2008

4. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial;D'Amico;JAMA,2004

5. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial;Denham;Lancet Oncol,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-Exposure to Stress-Inducing Agents Increase the Anticancer Efficacy of Focused Ultrasound against Aggressive Prostate Cancer Cells;Antioxidants;2022-02-09

2. Androgen deprivation therapy and side effects: are GnRH antagonists safer?;Asian Journal of Andrology;2021

3. GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity;Disease Markers;2020-11-25

4. Annexin A1 promotes the nuclear localization of the epidermal growth factor receptor in castration-resistant prostate cancer;The International Journal of Biochemistry & Cell Biology;2020-10

5. Metabolic changes in patients with prostate cancer with androgen deprivation therapy;Diabetes mellitus;2020-06-26